These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35586748)

  • 1. Serum Atrial Natriuretic Peptide,
    Chen L; Li J; Zhang M; Zhang Q; Wu L; Lu Y; He Y; Jiang J; Zhang X; Hu J; Ding Y; Zhang M; Peng H
    Glob Heart; 2022; 17(1):27. PubMed ID: 35586748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NPPA Promoter Hypomethylation Predicts Central Obesity Development: A Prospective Longitudinal Study in Chinese Adults.
    Li J; Zhu J; Zhang Q; Chen L; Ma S; Lu Y; Shen B; Zhang R; Zhang M; He Y; Wu L; Peng H
    Obes Facts; 2022; 15(2):257-270. PubMed ID: 34875662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between NPPA promoter methylation and hypertension: results from Gusu cohort and replication in an independent sample.
    Li J; Zhu J; Ren L; Ma S; Shen B; Yu J; Zhang R; Zhang M; He Y; Peng H
    Clin Epigenetics; 2020 Sep; 12(1):133. PubMed ID: 32883357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations among NPPA gene polymorphisms, serum ANP levels, and hypertension in the Chinese Han population.
    Zhang H; Mo X; Zhou Z; Zhu Z; HuangFu X; Xu T; Wang A; Guo Z; Zhang Y
    J Hum Hypertens; 2019 Sep; 33(9):641-647. PubMed ID: 31341238
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    He Y; Li Y; Zhang J; Chen L; Li J; Zhang M; Zhang Q; Lu Y; Jiang J; Zhang X; Hu J; Ding Y; Zhang M; Peng H
    Front Endocrinol (Lausanne); 2022; 13():873012. PubMed ID: 35399937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of causality of natriuretic peptides and atrial fibrillation and heart failure: a Mendelian randomization study in the FINRISK cohort.
    Geelhoed B; Börschel CS; Niiranen T; Palosaari T; Havulinna AS; Fouodo CJK; Scheinhardt MO; Blankenberg S; Jousilahti P; Kuulasmaa K; Zeller T; Salomaa V; Schnabel RB
    Europace; 2020 Oct; 22(10):1463-1469. PubMed ID: 32830215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Midregional pro atrial natriuretic peptide: a novel important biomarker for noise annoyance-induced cardiovascular morbidity and mortality?
    Hahad O; Wild PS; Prochaska JH; Schulz A; Lackner KJ; Pfeiffer N; Schmidtmann I; Michal M; Beutel M; Daiber A; Münzel T
    Clin Res Cardiol; 2021 Jan; 110(1):29-39. PubMed ID: 32306084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of multiple emerging biomarkers in cardiovascular risk prediction in patients with stable cardiovascular disease.
    Ahluwalia N; Blacher J; Szabo de Edelenyi F; Faure P; Julia C; Hercberg S; Galan P
    Atherosclerosis; 2013 Jun; 228(2):478-84. PubMed ID: 23582589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic control of natriuretic peptides: implications for health and disease.
    Rubattu S; Stanzione R; Cotugno M; Bianchi F; Marchitti S; Forte M
    Cell Mol Life Sci; 2020 Dec; 77(24):5121-5130. PubMed ID: 32556416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Corin Predicts the Risk of Cardiovascular Disease: A 10-Year Follow-Up Study.
    Chen L; Zhang Q; Zhang M; Yu J; Ren L; Li J; Ma S; He Y; Hu W; Peng H
    JACC Asia; 2022 Aug; 2(4):490-501. PubMed ID: 36339355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased plasma concentrations of midregional proatrial natriuretic Peptide is associated with risk of cardiorenal dysfunction in type 1 diabetes.
    Theilade S; Hansen TW; Goetze JP; Rossing P
    Am J Hypertens; 2015 Jun; 28(6):772-9. PubMed ID: 25468806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive utility of atrial, N-terminal pro-atrial, and N-terminal pro-B-type natriuretic peptides for mortality and cardiovascular events in the general community: a 9-year follow-up study.
    McKie PM; Cataliotti A; Sangaralingham SJ; Ichiki T; Cannone V; Bailey KR; Redfield MM; Rodeheffer RJ; Burnett JC
    Mayo Clin Proc; 2011 Dec; 86(12):1154-60. PubMed ID: 22134933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of B-Type Natriuretic Peptide and Its Coding Gene Promoter Methylation With Functional Outcome of Acute Ischemic Stroke: A Mediation Analysis.
    Wang A; Zhang M; Ding Y; Mo X; Zhong C; Zhu Z; Guo D; Zheng X; Xu T; Liu Y; Zhang Y; Peng H
    J Am Heart Assoc; 2020 Sep; 9(18):e017499. PubMed ID: 32875935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
    Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
    J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome-wide analysis of DNA methylation and risk of cardiovascular disease in a Chinese population.
    Gao Y; Pang H; Chen B; Wu C; Wang Y; Hou L; Wang S; Sun D; Zheng X
    BMC Cardiovasc Disord; 2021 May; 21(1):240. PubMed ID: 33980183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of midregional pro-A-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in patients with stable coronary heart disease followed over 8 years.
    Karakas M; Jaensch A; Breitling LP; Brenner H; Koenig W; Rothenbacher D
    Clin Chem; 2014 Nov; 60(11):1441-9. PubMed ID: 25139456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of midregional pro-A-type natriuretic peptide and the N-terminal pro-B-type natriuretic peptide for predicting mortality and cardiovascular events.
    van Hateren KJ; Alkhalaf A; Kleefstra N; Groenier KH; de Jong PE; de Zeeuw D; Gans RO; Struck J; Bilo HJ; Gansevoort RT; Bakker SJ
    Clin Chem; 2012 Jan; 58(1):293-7. PubMed ID: 21948291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking and Promoter-Specific Deoxyribonucleic Acid Methylation of the Atrial Natriuretic Peptide Gene: Methylation of Smokers and Non-Smokers Differs Significantly during Withdrawal.
    Glahn A; Rhein M; Frieling H; Schuster R; El Aissami A; Bleich S; Hillemacher T; Muschler M
    Eur Addict Res; 2017; 23(6):306-311. PubMed ID: 29339652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Natriuretic Peptides as Risk Markers for All-Cause Mortality and Cardiovascular and Renal Complications in Individuals With Type 1 Diabetes.
    Tofte N; Theilade S; Winther SA; Birkelund S; Goetze JP; Hansen TW; Rossing P
    Diabetes Care; 2021 Feb; 44(2):595-603. PubMed ID: 33323477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma mid-regional pro-atrial natriuretic peptide predicts cardiovascular events in patients with type 2 diabetes independently of subclinical organ damage.
    Gauffin E; Chisalita SI; Engvall J; Nyström FH; Östgren CJ
    Diabetes Res Clin Pract; 2021 Dec; 182():109095. PubMed ID: 34662688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.